Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.40 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28762450 | 0.89 | CA12 (0.40) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL3925327 | 0.89 | CA12 (0.51) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL25634109 | 0.88 | PIM1 (0.40) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL29321981 | 0.87 | DNMT1 (0.44) | DNMT1ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL25060814 | 0.87 | CA12 (0.44) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL29751906 | 0.87 | CA12 (0.49) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL16814673 | 0.87 | CA12 (0.49) | DNMT1CA12CA1CA2CA9 | |
| SCHEMBL19199345 | 0.86 | HPRT1 (0.50) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL24446252 | 0.85 | CA12 (0.55) | CA12CA1CA2CA9HDAC8 | |
| SCHEMBL2127807 | 0.83 | ALDH1A1 (0.46) | CA12CA1CA2CA9HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180596-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | LG CHEM, LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180596-A1 | Novel Compound and Organic Light Emitting Device Comprising the Same | CRY1, CRY2, CYBA | DNMT1 1993/4885CA12 1274/4885CA1 2878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.